Teladoc Health, Inc. (TDOC)

NYSE Currently down 0.19 (-2.94%) in today's trading session

3 members of Congress have disclosed 45 trades in Teladoc Health, Inc. (TDOC) via STOCK Act filings. The most recent disclosure was a sale by Donald S. Beyer on 26 November 2021. The most active traders have been Donald S. Beyer (36), Bradley Scott Schneider (8), and Gilbert Cisneros (1). Aggregate disclosed activity totals roughly $749.5K in purchases and $959.5K in sales (midpoint estimates from bracketed disclosure amounts).

Teladoc Health, Inc. is currently trading at $6.28, positioned at 34% of its 52-week range ($4.40 – $9.89).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$6.28
24h Change
-0.19 (-2.94%)
52 Week Range
$4.40$9.89
View on NASDAQ

Teladoc Health, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for TDOC

Select to highlight on chart
5 transactions
Compliance: 44%
Donald S. Beyer26 Nov 20212 Dec 2021SaleStock$1,001 - $15,000N/A
Donald S. Beyer18 Aug 20212 Sept 2021SaleStock$1,001 - $15,000N/A
Donald S. Beyer21 Jun 20214 Jul 2021SaleStock$1,001 - $15,000N/A
Donald S. Beyer7 May 20217 Jun 2021SaleStock$1,001 - $15,000N/A
Gilbert Cisneros19 Nov 202015 Dec 2020PurchaseStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.14B

Volume

2.95M

Beta

2.13

P/E Ratio

-6.34

Fundamentals

EPS

$-0.99

Div. Yield

-

Open

$6.34

Day Range

$6.25 – $6.42

Company Information

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NYSE · USD
Country
US
CEO
Charles Divita
IPO Date
2015-06-30

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and lo...

Earnings

Next Report

Q3 2026

28 Oct

EPS Est.

$-0.21

Rev. Est.

$590.3M

Days Until

51

Recent Quarters

Q2 202629 Jul
EPS$-0.21
Beat 15.9%
Q1 202629 Apr
EPS$-0.36
Miss 5.5%
Q4 202525 Feb
EPS$-0.14
Beat 26.3%
Q3 202529 Oct
EPS$-0.28
Miss 7.7%
Q2 202529 Jul
EPS$-0.19
Beat 29.6%
Q1 202530 Apr
EPS$-0.53
Miss 60.6%
Q4 202426 Feb
EPS$-0.28
Miss 21.7%
Q3 202430 Oct
EPS$-0.19
Beat 32.1%
Q2 202431 Jul
EPS$-0.28
Beat 20.0%
Q1 202425 Apr
EPS$-0.49
Miss 6.5%
Q4 202320 Feb
EPS$-0.17
Beat 19.1%
Q3 202324 Oct
EPS$-0.35
Beat 5.4%
Q2 202325 Jul
EPS$-0.40
Beat 2.4%
Q1 202326 Apr
EPS$-0.42
Beat 16.0%
Q4 202222 Feb
EPS$-0.23
Beat 14.8%
Q3 202226 Oct
EPS$-0.45
Beat 21.1%
Q2 202227 Jul
EPS$-19.22
Miss 3045.5%
Q1 202227 Apr
EPS$-41.58
Miss 7325.0%
Q4 202122 Feb
EPS$-0.07
Beat 87.5%
Q3 202127 Oct
EPS$-0.53
Beat 18.5%
Q2 202127 Jul
EPS$-0.86
Miss 53.6%
Q1 202128 Apr
EPS$-1.31
Miss 129.8%
Q4 202024 Feb
EPS$-3.07
Miss 1128.0%
Q3 202028 Oct
EPS$-0.43
Miss 30.3%
Q2 202029 Jul
EPS$-0.34
Miss 47.8%
Q1 202029 Apr
EPS$-0.40
Miss 11.1%
Q4 201926 Feb
EPS$-0.26
Beat 21.2%
Q3 201930 Oct
EPS$-0.28
Beat 30.0%
Q2 201931 Jul
EPS$-0.41
Beat 0.0%
Q1 201930 Apr
EPS$-0.43
Beat 2.3%
Q4 201827 Feb
EPS$-0.35
Beat 2.8%
Q3 20181 Nov
EPS$-0.34
Beat 5.6%
Q2 20181 Aug
EPS$-0.40
Miss 8.1%
Q1 20181 May
EPS$-0.36
Beat 16.3%
Q4 201727 Feb
EPS$-0.76
Miss 90.0%
Q3 20171 Nov
EPS$-0.55
Miss 5.8%
Q2 20172 Aug
EPS$-0.28
Miss 7.7%
Q1 20178 May
EPS$-0.30
Beat 11.8%
Q4 20161 Mar
EPS$-0.29
Beat 17.1%
Q3 201627 Oct
EPS$-0.33
Beat 5.7%
Q2 20163 Aug
EPS$-0.38
Beat 2.6%
Q1 201610 May
EPS$-0.40
Miss 5.3%
Q4 20152 Mar
EPS$-0.39
Beat 4.9%
Q3 20152 Nov
EPS$-0.35
Beat 0.0%
Q2 201512 Aug
EPS$-0.46
Miss 7.0%
Q1 201524 Jun
EPS$-0.35
Q1 201529 May
EPS$-0.25
Q2 201430 Sept
EPS$-0.16
Q1 201430 Jun
EPS$-0.12
Q4 201331 Mar
EPS$-0.08

10 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

AAPL

Apple Inc.

22
$319.97-8.24 (-2.51%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

SPY

State Street SPDR S&P 500 ETF Trust

17
$770.19-2.98 (-0.39%)
Financial Services
Held by same politician
1 politician
View Stock

WBI

WaterBridge Infrastructure LLC

17
$32.21-0.03 (-0.09%)
Energy
Held by same politician
1 politician
View Stock

Frequently Asked Questions about TDOC

Which members of Congress have traded TDOC?
3 members of Congress have disclosed 45 trades in Teladoc Health, Inc. (TDOC) under the STOCK Act. The most active traders are Donald S. Beyer, Bradley Scott Schneider, and Gilbert Cisneros.
When was TDOC most recently disclosed by Congress?
The most recent TDOC disclosure was a sale by Donald S. Beyer on 26 November 2021.
What is the total disclosed congressional trading volume for TDOC?
Members of Congress have disclosed approximately $749.5K in TDOC purchases and $959.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in TDOC?
This TDOC page updates as soon as new STOCK Act disclosures are filed for Teladoc Health, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.